National Health Valuation
| GEGR Stock | USD 0.02 0 14.00% |
National Health seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of National Health Scan from analyzing the firm fundamentals such as Number Of Employees of 3, net income of (661.31 K), and Net Asset of 455 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that National Health's price fluctuation is out of control at this time. Calculation of the real value of National Health Scan is based on 3 months time horizon. Increasing National Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the National pink sheet is determined by what a typical buyer is willing to pay for full or partial control of National Health Scan. Since National Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of National Pink Sheet. However, National Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0228 | Real 0.0174 | Hype 0.02 | Naive 0.0222 |
The intrinsic value of National Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence National Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of National Health Scan helps investors to forecast how National pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of National Health more accurately as focusing exclusively on National Health's fundamentals will not take into account other important factors: National Health Total Value Analysis
National Health Scan is currently forecasted to have valuation of 0 with market capitalization of 0, debt of 36 K, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the National Health fundamentals before making equity appraisal based on enterprise value of the companyNational Health Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of National connotes not a very effective usage of assets in November.National Health Profitability Analysis
Net Loss for the year was (661.31 K) with profit before overhead, payroll, taxes, and interest of 0.About National Health Valuation
The pink sheet valuation mechanism determines National Health's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of National Health Scan based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of National Health. We calculate exposure to National Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of National Health's related companies.iWeb Corporation operates as a medical or healthcare industry business incubator. Among the businesses it has nurtured are Radiology.com, an Internet-based radiology services and systems company, and WebMRI.com, an MRI systems design and OEM company. iWeb Corporation was founded in 1995 and is based in Los Angeles, California. GAENSEL ENERGY operates under Conglomerates classification in the United States and is traded on OTC Exchange.
8 Steps to conduct National Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates National Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct National Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain National Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine National Health's revenue streams: Identify National Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research National Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish National Health's growth potential: Evaluate National Health's management, business model, and growth potential.
- Determine National Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate National Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
National Health Growth Indicators
Investing in growth stocks can be very risky. If the company such as National Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -9.9 M |
Additional Tools for National Pink Sheet Analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.